Shilpa Medicare soars over 11% to record high on positive phase 3 trial results for fatty liver drug NorUDCA

Shilpa Medicare soars over 11% to record high on positive phase 3 trial results for fatty liver drug NorUDCA

Shilpa Medicare shares surged over 11 percent to its record high after the company announced a successful outcome in Phase 3 studies for SMLNUD07, a drug known as NorUDCA. This medication is designed to treat patients with Nonalcoholic Fatty Liver Disease (NAFLD). Shilpa Medicare shares skyrocketed over 11 percent to reach a record high following …

Read more

USAID, Takeda Biopharma launch dengue prevention programme across India | Company News

USAID, Takeda Biopharma launch dengue prevention programme across India | Company News

The vaccine is already available for children and adults in the private market in Europe, Indonesia, and Thailand, and in some public programmes in Argentina and Brazil Image credit: USAID’s X account, handle: @usaid_india BS Reporter New Delhi The United States Agency for International Development (USAID) and Takeda Biopharmaceuticals India on Friday announced the launch …

Read more

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

The latest changes come in the backdrop of a number of episodes involving India-made drugs, especially cough and cold syrups, being linked with adverse events including deaths in several countries, purportedly due to contamination with harmful chemicals. In September, ThePrint had reported that the government was working to make GMP norms more thorough for drugmakers. …

Read more

Investment firm to acquire pharmaceutical major in India, marking crucial investment in pharma sector

Investment firm to acquire pharmaceutical major in India, marking crucial investment in pharma sector

Image Source : PEXELS Picture of thermometer on medical pills IQuest Enterprises, a multi-sector investment company, on Monday said it has entered into a definitive agreement to acquire the API (active pharmaceutical ingredient) operations of global pharmaceutical major Viatris in India. A press release from IQuest said it emerged as the preferred investor following a …

Read more